Is Take Solutions a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Take Solutions Ltd is a below average quality company .

Is Take Solutions undervalued or overvalued?

The key valuation ratios of Take Solutions Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone .

What is Take Solutions share price return in the past 10 years?

Take Solutions Ltd share price has declined -11.4% annually (CAGR) over the past ten years.

Is Take Solutions a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Take Solutions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Take Solutions Ltd - Stock Valuation and Financial Performance

Name: Take Solutions
Brand: Take Solutions

BSE: 532890 | NSE: TAKE | IT - Software | Small Cap

Place order

Take Solutions Share Price

₹16.26 -0.56 -3.33%
as on 20-Dec'24 16:59

10 Year X-Ray of Take Solutions:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis ^P

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	4.2%	5.8%	3.9%	2.5%	2.6%	1%	-0.9%	-0.5%	1.8%	-101.7%	-
Value Creation Index ⓘ	-0.7	-0.6	-0.7	-0.8	-0.8	-0.9	-1.1	-1.0	-0.9	-8.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	25.9	23.6	18.8	2.4	22	2.5	12	18	56.2	5.4	5
Sales YoY Gr.	-	-9%	-20.1%	-87.1%	800%	-88.8%	387%	49.6%	212.4%	-90.4%	-
Adj EPS ⓘ	0.5	0.7	0.2	0.3	0.5	0.2	-0.2	-0.5	0.5	-5.4	-14
YoY Gr.	-	37.3%	-67.1%	43.5%	36.4%	-62.2%	-235.3%	NA	NA	-1107.4%	-
BVPS (₹) ⓘ	26.4	26.5	38.3	51.5	50.9	51	51.7	19.5	20.4	6.5	6.5
Adj Net Profit ⓘ	6.1	8.4	3	4.8	6.7	2.5	-3.4	-7.7	8	-80.4	-207
Cash Flow from Ops. ⓘ	-2.6	-10.8	-33	-24	12.9	-14.9	-2.7	32.6	26.9	-4.5	-
Debt/CF from Ops. ⓘ	0	-6.8	0	0	0	0	0	0	0	0	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-16%	-24.4%	-23.3%	-90.4%
Adj EPS ⓘ	-230.1%	-264.6%	NA	-1107.4%
BVPSⓘ	-14.5%	-33.9%	-50%	-68.3%
Share Price	-11.4%	-30.1%	-29.6%	-32.6%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	1.9	2.6	0.7	0.8	0.9	0.3	-0.4	-1.4	2.7	-40.4	-217.2
Op. Profit Mgn % ⓘ	5.6	22.1	-16.7	-664.4	-63.2	-685.8	-25.8	-74.2	5.1	-394.7	18.6
Net Profit Mgn % ⓘ	23.4	35.6	16.2	197.2	30.3	101.7	-28.2	-42.6	14.2	-1483.7	-3823
Debt to Equity ⓘ	0	0.2	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	625	789	1,936	26,120	3,642	35,731	7,599	3,694	585	2,813	0
Cash Conv. Cycle ⓘ	-179	-130	-17	272	34	979	75	-79	-314	-261	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -23.34%

Sales growth is not so good in last 4 quarters at -89.37%

Latest Financials - Take Solutions Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-14	-8.1
TTM Sales (₹ Cr.)	5.4	65.6
BVPS (₹.) ⓘ	6.5	-0.6
Reserves (₹ Cr.) ⓘ	81	-23
P/BV ⓘ	2.52	-27.64
PE ⓘ	0.00	0.00

From the Market
52 Week Low / High (₹)	16.10 / 35.78
All Time Low / High (₹)	4.70 / 308.30
Market Cap (₹ Cr.)	241
Equity (₹ Cr.)	14.8
Face Value (₹)	1
Industry PE ⓘ	36

Management X-Ray of Take Solutions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Take Solutions

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Take Solutions

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	26	24	19	2	22	2	12	18	56	5
Operating Expenses ⓘ	24	18	23	19	36	19	19	31	53	27
Manufacturing Costs	0	0	0	1	1	1	0	1	1	0
Material Costs	0	0	0	0	0	0	0	0	0	0
Employee Cost	2	3	6	5	7	6	4	4	3	2
Other Costs ⓘ	22	16	17	13	28	12	14	26	50	25
Operating Profit ⓘ	1	5	-4	-16	-14	-17	-7	-13	3	-22
Operating Profit Margin (%)	5.6%	22.1%	-20.8%	-664.0%	-63.2%	-685.0%	-57.1%	-74.2%	5.1%	-406.0%
Other Income ⓘ	13	16	22	33	34	26	1	17	9	1
Interest ⓘ	0	0	3	1	0	0	0	0	1	1
Depreciation ⓘ	1	0	1	1	1	2	2	1	1	1
Exceptional Items ⓘ	0	0	0	0	0	0	0	-5	-5	-181
Profit Before Tax ⓘ	13	20	15	15	20	7	-7	-3	5	-203
Tax ⓘ	2	2	0	-1	2	-1	-1	2	0	4
Profit After Tax	11	18	14	15	17	8	-6	-5	4	-207
PAT Margin (%)	43.7%	77.3%	76.5%	625.6%	79.2%	313.7%	-50.1%	-28.4%	7.6%	-3,823.1%
Adjusted EPS (₹)	0.9	1.5	1.1	1.0	1.2	0.5	-0.4	-0.4	0.3	-14.0
Dividend Payout Ratio (%)	106%	66%	92%	155%	85%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	316	319	511	762	753	755	764	288	301	95
Share Capital ⓘ	12	12	13	15	15	15	15	15	15	15
Reserves ⓘ	304	307	497	747	738	740	750	273	286	81
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	0	73	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	73	0	0	0	0	0	0	0	0
Trade Payables	2	4	1	1	0	1	2	4	5	1
Others Liabilities ⓘ	7	18	21	12	19	19	18	19	12	23
Total Liabilities ⓘ	325	414	533	775	773	774	784	312	318	119
Fixed Assets
Gross Block	43	42	5	5	5	10	10	10	10	0
Accumulated Depreciation	42	42	1	2	2	4	6	7	8	0
Net Fixed Assetsⓘ	1	0	5	4	3	6	4	3	2	0
CWIP ⓘ	0	2	0	0	0	0	0	0	0	0
Investmentsⓘ	234	330	360	414	512	517	517	155	243	102
Inventories	0	0	0	0	0	0	0	0	0	0
Trade Receivables	3	4	3	1	6	7	2	4	0	0
Cash Equivalents	44	24	25	152	25	1	12	3	7	1
Others Assetsⓘ	43	52	140	204	227	243	249	147	67	17
Total Assets ⓘ	325	414	533	775	773	774	784	312	318	119

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-3	-11	-33	-24	13	-15	-3	33	27	-4
PBT ⓘ	13	20	15	15	20	7	7	-474	5	-203
Adjustment ⓘ	-5	-6	3	-3	-18	-12	-19	468	-1	202
Changes in Working Capital ⓘ	-8	-22	-46	-33	12	-8	10	40	28	-2
Tax Paid ⓘ	-2	-2	-5	-3	-1	-1	0	0	-4	-1
Cash Flow From Investing Activity ⓘ	55	-92	-24	-88	-112	22	13	-40	-22	-1
Capex	0	-2	-3	0	0	0	17	0	0	0
Net Investments	50	-91	-25	-50	-93	23	0	0	0	0
Others ⓘ	5	2	4	-38	-19	-1	-4	-40	-22	-1
Cash Flow From Financing Activityⓘ	-12	61	58	239	-28	-8	0	-1	-1	0
Net Proceeds from Shares ⓘ	0	0	173	250	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	-3	-1	0	0	0	0	0	0
Dividend Paid ⓘ	-12	-12	-13	-13	-28	-7	0	0	0	0
Others ⓘ	0	73	-99	4	0	-1	0	-1	-1	0
Net Cash Flow ⓘ	41	-42	1	127	-127	-1	11	-9	4	-6

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	3.56	5.74	3.48	2.4	2.3	1.03	-0.79	-0.97	1.46	-104.51
ROCE (%)	4.24	5.84	3.88	2.46	2.57	0.97	-0.9	-0.46	1.79	-101.71
Asset Turnover Ratio	0.08	0.06	0.04	0	0.03	0	0.02	0.03	0.18	0.02
PAT to CFO Conversion(x)	-0.27	-0.61	-2.36	-1.6	0.76	-1.88	N/A	N/A	6.75	N/A
Working Capital Days
Receivable Days	40	52	67	306	61	994	142	68	0	0
Inventory Days	0	1	1	16	2	4	0	0	0	0
Payable Days	0	0	0	0	0	0	0	0	0	0

Take Solutions Ltd Stock News

Take Solutions Ltd FAQs

What is the share price of Take Solutions?

Company share prices are keep on changing according to the market conditions. The closing price of Take Solutions on 20-Dec-2024 16:59 is ₹16.26.

What is the market cap of Take Solutions?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Dec-2024 16:59 the market cap of Take Solutions stood at ₹240.5.

What is the P/E ratio of Take Solutions?

The latest P/E ratio of Take Solutions as of 20-Dec-2024 16:59 is 0.00.

What is the P/B ratio of Take Solutions?

The latest P/B ratio of Take Solutions as of 20-Dec-2024 16:59 is 2.52.

What is the 52-week high and low of Take Solutions?

The 52-week high of Take Solutions is ₹35.78 and the 52-week low is ₹16.10.

What is the TTM revenue of Take Solutions?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Take Solutions is ₹5.42 ( Cr.) .

About Take Solutions Ltd

TAKE Solutions is a globally-recognized domain-leader in Life Sciences and Supply Chain Management. TAKE leverages its domain expertise, innovation-driven technology, best practices and people strength to offer clients transformative full services across clinical development, and point services in supply chain. In the fast-growing Life Sciences space, TAKE offers clients a unique combination of full-service Clinical, Regulatory and Safety services backed by unique technology expertise. Its range of services span from clinical trials to regulatory submissions to post-marketing safety, all backed by insights derived through proprietary industry networks forums.

With a team of leading Life Sciences experts, best-in-class systems and processes, and bespoke, industry-specific technology and analytics, TAKE delivers successful outcomes for clients. Its global roster of clients includes large and small innovator biopharmaceutical companies as well as generics manufacturers. In Supply Chain Management, TAKE focuses on high-margin niches in engineering services, and supply chain collaboration. Its IP-led approach enables its clients to automate supply chain processes, track, trace & control at item level, mandate supplier compliance, and streamline material & shipment movement, and thus optimize their processes. With operations spread across North America, Europe, Asia, and South America, TAKE is a Public Company, listed in India on the Bombay Stock Exchange and the National Stock Exchange.

Business area of the company

The company delivers domain-intensive services in Life Sciences and Supply Chain Management. The company offers clients a unique combination of full service Clinical, Regulatory and Safety services with unique technology expertise. The Company's services span clinical trials to regulatory submissions to post-marketing strategy with insights derived through proprietary industry network forums.

Products and services

Life Sciences:

Life sciences home: implementation of clinical data standards for sponsor process enhancement and preparation of compliant clinical data. Services focused on leveraging the standardization process into Clinical Study and Summary (ISS/ISE) reports.
Clinical data offerings: SDTM consultation and Full clinical data lifecycle services, from CRF design to ISS/ISE.
Regulatory offerings: PharmaReady, an exclusive brand of TAKE Solutions, is a fully integrated web-based eDMS and eCTD Submissions Solution Suite.
Drug safety offerings: Complete Pharmacovigilance Safety System and Clinical Trials Safety Surveillance.

Supply Chain Management:

Demand Driven Supply Network
Demand Driven Distribution & Fulfillment
Mobile Applications & Auto-ID
Global Trade Management

Company’s technology products and solutions are:

Business Process Management Solutions- TAKE RTE (real time enterprise)
TAKE BI Solutions, the Business Intelligence practice of TAKE Solutions, delivers custom solutions that enable companies to tap the full potential of their business capabilities by helping them access, analyze and share information anytime and anywhere.
Microsoft solutions
Enterprise desktop management solutions

Awards

2008: Recognized by Deloitte as India’s 10th fastest growing technology company
2009: Listed in Food Logistics magazine’s FL 100+ Software & Technology Providers list for third consecutive year
2010: Received MMA (Madras Management Association) award for Managerial Excellence 2010 in the Services category
2010: Recognized by Supply Chain Brain as a Great Supply Chain Partner 2010 for fourth consecutive year
2012: Recognized for “Significant Contribution to SCM field” at Spectrum Confluence 2012 organized by Indian Institute of Materials Management (IIMM) Chennai
2012: Listed on the 2012 Supply and Demand Chain Executive 100 List for the second consecutive year
2012: Recognized as TOP 100 Logistics IT Providers by Inbound Logistics magazine
2013: Emerged as Asia’s Second Best Employer Brand. Declared as Best among 30 Companies from across 33 countries in Singapore
2013: Recognized by Supply Chain Brain’s “2012 Great Supply Chain Partner” list
2013: Named in Software Magazine’s 30th Annual Software 500 as one of the world’s largest software and service companies
2013: Ranked by Inc. India magazine as one of India’s fastest growing top 500 mid-size companies
2014: Won the Best Employer Brand Award at the World HRD Congress, with a total of 14 award wins
2014: Named in 2013 Supply and Demand Chain Executive 100
2014: Listed in Software Magazine’s 31st ‘Annual Software 500’ ranking for the second consecutive year
2015: Ranked 2nd as the Dream Employer of Year, in Technology, at the World HRD Congress, with a total of 16 award wins
2015: Named in Software Magazine’s 32nd Annual Software 500 ranking of the world’s largest software and service providers for the third consecutive year
2016: Received a Special Commendation for Excellence in Corporate Governance at the Golden Peacock Awards
2016: Declared ‘HR Company of the Year’ from amongst over 400 companies at the World HRD Congress
2016: Adjudged the ‘Most Admired Brand – IT’ at the 5th Asian Customer Engagement Forum Awards that recognize excellence in Branding, Marketing and CSR
2017: Received the Golden Peacock Award for Excellence in Corporate Governance
2017: Chosen as one of the ‘Great Places to Work’ for its exemplary workplace culture
2017: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
2017: Received awards for the ‘Most Effective Campaign’, “Best use of video content’ and ‘Best Media Relations/PR at the prestigious Asian Customer Engagement Forum Awards
2017: Received titles of ‘Dream Company to Work For’ and ‘Best Employer Brand’, and 27 other titles at the World HRD Congress
2018: Won the award for Best Employer Brand for the 2nd consecutive year at the World HRD Congress 2018, and ranked 3rd in the Times Ascent presents Dream Companies to Work For category
2018: Earned a place in the Great Place to Work global listing, the global authority on building, sustaining & recognizing exemplary workplace culture and best practices
2018: Bestowed with the Golden Peacock Award for Excellence in Corporate Governance, for the 2nd consecutive year in 2018
2019: Awarded Silver recognition level by EcoVadis for Sustainability & CSR Performance
2020: CEO Insights Top 10 Clinical Trials Service Providers - 2020

Milestones

2000-2004

Inaugurated North American headquarters at Princeton, New Jersey, USA
TAKE Solutions was founded in Chennai, India

2007-2010

Inaugurated a state-of-the-art global delivery center in Chennai, India
Acquired OnSphere Corporation, Raleigh, North Carolina, USA, an IP-driven leader in regulatory compliance for Life Sciences
Launched OneSCM, a multi-tenant SaaS platform to improve enterprise supplier management
Acquired ClearOrbit, a Supply Chain Management software company in Austin, Texas, USA
Registered a successful IPO and listed on the Bombay Stock Exchange and the National Stock Exchange in India.

2011-2014

Recognized as a leader in IDC MarketScape on Drug Safety Services Worldwide Life Science Drug Safety Services 2013 Vendor Assessment
Acquired UK-based WCI Consulting Group, a leading patient safety and compliance advisor to the Life Sciences industry
Launched SafetyReady to increase the efficiency of Oracle Argus Safety Suite for Life Sciences
Recognized as a Leader in IDC MarketScape: Worldwide Life Sciences R&D IT Outsourcing 2011

2015

Launched cdsnet, a proprietary industry network on Clinical Data Strategy
Launched Latin American Regulatory Operations Hub in Bogota, Columbia
Awarded patent by the United States Patent and Trademark Office (USPTO) for “Method for Optimizing Clinical Data Standardization”
Launched India’s first propriety industry network on pharmacovigilance, pvindia
Launched pharmaReady 6.0, an update to proprietary web-based electronic document management and eSubmission solution for Life Sciences

2016

Acquired Ecron Acunova, a full-service CRO with Clinical & BA/BE capabilities
100th pharmaReady customer win

2017

Navitas Life Sciences named as a Leader in IDC MarketScape: Worldwide Life Science Drug Safety Services 2017 Vendor Assessment
Consolidated Life Sciences businesses under the brand Navitas Life Sciences to provide full services across Clinical, Regulatory and Safety
Launched Labeling Assessment Express to improve End-to-End labeling for Life Sciences
Celebrated the landmark 15th year of its proprietary Life Sciences industry network forums
Updated and significantly expanded OneSCM Supply Chain Collaboration Suite
Launched the Gemini Series Android App for Smartphones

2018

Inaugurated satellite hub in Chennai to deliver end-to-end dossier submission for APAC region for one of the largest global pharma companies
Navitas Life Sciences recognized as ‘Leader’ in the IDC MarketScape: Drug Safety Services 2018 Vendor Assessment as one of only 8 vendors selected based on stringent research and due diligence
Expanded operations in Colombia to offer full-service clinical, regulatory and pharmacovigilance/safety and technology offerings across Latin America
Gartner recognized the Company amongst Top 20 Global Solution Providers in its Market Guide for Track-and-Trace and Serialization Software Providers for Life Sciences Companies
TAKE recognised in CIO Review’s ‘20 Most Promising Pharma and Life Sciences Tech Companies'
Inaugurated state-of-the-art Clinical facility in Chennai to conduct Bioavailability & Bioequivalence studies

2019-20

Everest Group's Life Sciences Clinical Trials Products PEAK Matrix Assessment 2019 recognized Navitas Life Sciences as a Major Contender
Acquired US-based, full-service contract research organization (CRO) and health-research company KAI Research
Acquired DataCeutics, an American Clinical Data Sciences services company that provides quality SAS based statistical programming, clinical reporting and clinical data management
175+ customers for pharmaREADY, its cloud-based Regulatory Submissions management platform